Arsenic trioxide in combination with all-trans retinoic acid (ATRA) is recommended to be available as a routine commissioning treatment option for high-risk acute promyelocytic leukaemia (APML) within ...
Their oral formulation of arsenic trioxide (Oral-ATO; Arsenol) for acute promyelocytic leukaemia (APL) , an incurable disease, is the first prescription medicine wholly invented and manufactured.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback